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ABSTRACT 
 
As the obesity epidemic continues to affect the chronic disease status of individuals 
worldwide, research that aims to elucidate the contribution of maternal health status to the 
perpetuation of the obesity cycle has become increasingly prevalent. We sought to answer 
how different time point interventions in maternal diet affect characteristics of obesity and 
presence of inflammation in the visceral adipose tissue of offspring male mice. Addressing 
this question, female mice were continued on either a high-fat diet or transitioned from a 
high-fat diet to a low-fat diet at 1, 5 or 9 weeks prior to pregnancy. Offspring male mice 
were continued on a HFD for 12 weeks post-weaning. Compared to NF group, the H1N 
group had significantly increased adipocyte diameter indicative of hypertrophy, while the 
H5N and H9N offspring had rescued adipocyte hypertrophy although the H5N adipocyte 
was significantly bigger than the HF offspring. Accordingly, the H1N and H5N offspring 
increased expression of key adipogenesis and fat trafficking genes compared to the NF 
group, which was totally reversed in H9N offspring, respectively. F4/80 positive cells 
indicated decreased number of adipose tissue macrophage in H9N offspring than NF 
offspring. However, there was increased ATM infiltration in H1N and H5N, compared to 
the HF offspring.   Consistently, the H9N offspring also had the least amount of crown 
like structures among all groups. Additionally, the H1N offspring had the highest 
expression of Tnf-α and Il-6 among all groups, while the H9N offspring expressed the 
similar level as the NF offspring, indicating enhanced adipose tissue inflammation in H1N 
offspring, which was completely reversed in H9N offspring. This result was echoed by 
significant upregulation of Jnk and Nf-κB in H1N group, but not H5N or H9N.  In 
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conclusion, our study showed that a long-term, but not a short-term transition from HFD 
to NFD before pregnancy is efficient to block the adipocyte hypertrophy and adipose 
tissue inflammation induced by maternal HFD. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
As of 2016, approximately 41 million children globally were affected by 
childhood obesity, an increase of roughly 9 million children since the year 1990 (1). 
These rates are expected to continue their increase at an alarming rate, and diagnosis of 
chronic diseases, which have previously been identified only in adults, such as type 2 
diabetes mellitus (adult-onset) and nonalcoholic fatty liver disease, are now being 
reported in pediatric clinical settings (2). This has resulted in further strain on healthcare 
systems, costing approximately $147 billion for disease management and treatment 
related to obesity in 2008 (3). Thus, shifting focus from treating obesity to preventing 
obesity is critical to ensure health of future generations. Strategies which offer means to 
address this issue are diverse, however, current research suggests that mitigating rates of 
pre-pregnancy obesity and gestational weight gain may be major influential factors to 
reduce aberrant metabolic programming and risk of developing chronic disease in 
offspring (4). 
The Intergenerational Cycle of Obesity theory focuses on how maternal obesity 
propagates risk of development of chronic disease through exacerbation of inflammation 
and diminished function of metabolic pathways in offspring, priming another generation 
for the same fate as the mother (4-6). Pregnancy is a time of both subtle and pronounced 
changes in hormone status, inflammation, weight, and diet. Excessive weight gain and 
pre-existing maternal obesity can disrupt these natural changes, triggering increased risk 
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of maternal gestational diabetes, preeclampsia, and uncontrolled fetal exposure to 
inflammatory factors and circulating energy in utero (7). Research has indicated that a 
myriad of modifiable environmental and epigenetic factors such as micronutrient intake 
and methylation status may impact offspring outcomes (8-10). Targeting the critical 
window immediately prior to gestation by providing feasible, adherable, lifestyle 
modifications may assist in delaying or reversing the intergenerational cycle of obesity 
and aberrant metabolic outcomes in both mother and offspring.  
1.1 Maternal Factors Affect Offspring Obesity 
1.1.1 Maternal Obesity 
By current estimates, the proportion of women who are of both childbearing age 
and overweight or obese (BMI >25) is two thirds (11). Understanding how maternal 
obesity, rather than dietary composition or overfeeding, influences developmental 
programming has proven cumbersome, as studies utilizing animal models typically 
initiate specific feeding protocols that span the duration of pregnancy and lactation. A 
study conducted by Shankar et al. (12) utilized pre-conceptually obese dams given a 
standard chow diet throughout pregnancy whose pups were cross-fostered with lean 
mothers to model effect of maternal weight on offspring. When offspring of both lean 
and obese dams were fed the same chow diet as their mothers, no body weight difference 
existed between pups of either obese or lean mothers. When pups of obese mothers 
consumed a high fat diet, however, substantial increase in body weight occurred, more 
so than pups of lean mothers fed a high fat diet. This indicates a critical role that 
maternal obesity may have on fetal programming and development of offspring obesity.  
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Maternal Pre-pregnancy BMI as well as percent ideal body weight are both 
significantly associated with increased risk of large for gestational age (LGA) babies and 
adolescent obesity (13-14).  In human studies, elucidating the role of maternal adiposity 
in fetal outcomes is challenged by genetic and environmental variations of clinical trial 
participants such as different dietary composition and intake patterns between 
households and family history of disease. Employing a sibling study, Smith et al. (15) 
followed 111 children born to women before and after undergoing anti-obesity surgery 
to compare body weights, lipid profiles and insulin sensitivity. Results indicated that 
mothers with approximately 36% body weight loss over a mean of 12 years gave birth to 
children with overall reductions in macrosomia, leptin and c- reactive protein, and 
improvements in insulin sensitivity, and lipid profile as compared to children born 
before maternal weight loss surgery. This result is consistent with a study conducted by 
Kral et al. (16) of a similar design which saw decreases in prevalence of obesity and 
overweight status in post-surgery births, tracked through seven years of age, illustrating 
the drastic alterations to pre-pregnancy weight may have on neonatal outcomes.  
Central obesity, identified by an increase in waist circumference and size of 
visceral adipose tissue depots, poses an increased risk for endocrine and immune 
dysfunction. Straughen et al. (17) tracked pregnancy-induced modifications to the 
location of adipose tissue storage, based on weeks of gestation, to determine in what 
ways the body preferentially stores excess energy during pregnancy.  It was concluded 
that visceral adipose tissue deposition was enhanced as compared to subcutaneous 
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adipose tissue stores, in pregnancies of both normal weight and obese women, indicating 
a gestation-based preference for visceral adiposity.  In women who have pre-existing 
central obesity, further accumulation of visceral adipose tissue may increase risk of 
complication for both mother and baby.   
1.1.2 High Fat Diet 
Excessive caloric intake and inadequate energy expenditure or “positive energy 
balance” has largely been targeted by dietitians and medical professionals as the 
underlying reason for increased weight status of individuals. Dietary studies have 
identified that meal composition, in addition to quantity of food consumed, are essential 
factors for understanding the development of obesity (18-19). Diets high in fat and 
refined carbohydrates are preferentially utilized for energy storage, leading to increases 
in adipocyte hypertrophy, expansion of visceral and subcutaneous adipose tissue depots 
and infiltration of adipose tissue into non-adipose organs (20). Parallel studies of humans 
and animals have indicated that in-utero exposure to over-nutrition results in an 
increased risk of developing impairments in insulin sensitivity, glucose tolerance and 
fatty liver beyond infancy (21-22) and is associated with increased visceral adiposity.  
Visceral adiposity is a potent effector of satiety and food intake through signaling 
mechanisms with the central nervous system (23). Evaluation of neurological feeding 
mechanisms of offspring born to high fat fed dams noted a significant increase in leptin 
levels in white adipose tissue immediately post-partum followed by decrease in levels 
accompanied by prolonged leptin resistance that was correlated with loss of sensitivity to 
 5 
 
food intake leading to obesity in rats (24). Loss of leptin sensitivity as a feedback 
mechanism can perpetuate obesity and excessive caloric intake.  
Diet “mismatch” is an effective research tool used to evaluate how administration 
of high fat diet after consumption of normal fat diet- or vice versa- can impact offspring 
phenotype. A study utilizing a strain of out-bred mice with genetic variance more similar 
to humans, used a diet mismatch model to explore how timing of diet administration 
effected outcomes in male mice.  Mice were fed a high fat diet either prior to gestation 
only or were continued on high fat diet through early gestation and then switched to a 
chow diet. Pups were then cross fostered with lean dams throughout weaning, followed 
by adherence to either a high fat diet or chow diet until sacrifice. Results concluded that 
offspring male mice fed a high fat diet experienced a more severe phenotype of 
adiposity, hyperinsulinemia and hyperleptinemia than control counterparts, even when 
mothers were exposed to HFD for only a short, developmentally early period of time 
(25). This programming effect of HFD consumption is supported by a study by Sasson et 
al. (26) that used a reciprocal embryo implantation model to determine how the exposure 
period of high fat diet-either preconception or during gestation led to more severe 
phenotypes in offspring fed a chow diet after weaning. Their work determined that 
maternal HFD exposure preconception altered placental gene expression and stunted 
intrauterine growth of the fetus, more so than gestation-based exposure. These studies 
indicate that HFD may play a vital role in metabolic programming of the neonate at the 
embryonic stage, potentially independent of maternal adiposity, which may be carried 
through later life as an inherent risk factor for chronic metabolic disease.  
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1.1.3 Gestational Weight Gain 
The Institute of Medicine has released guidelines stipulating relative amount of 
ideal weight gain throughout pregnancy, based on pre-pregnancy BMI (27). These 
guidelines utilize stricter margins for higher weight classes, to prevent fetal energy over 
exposure in utero. However, these guidelines continue to face scrutiny due to their 
overarching lack of detail in regard to ideal dietary composition and effective lifestyle 
change prior to and during pregnancy, leaving many healthcare professionals deficient in 
evidence-based tools to execute the guidelines.  
Failure to adhere to growth curves, evidenced by increased infant weight gain in 
relation to age, is predictive of overweight or obese status in childhood (28). Multiple 
studies have indicated that women who are obese prior to becoming pregnant, are more 
likely than their normal weight counterparts, to be affected by excessive gestational 
weight gain (29-31), increasing the likelihood that a neonate will be born large for 
gestational age (LGA).  A 3% increase in likelihood of adolescent obesity has been 
correlated to every 1 Kg increment in excessive gestational weight gain when children 
were tracked to age seven (32).   
Additionally, overweight and obese women who gain excessive gestational 
weight are at an increased risk for retaining that weight post-partum that may result in an 
increase in BMI (33-34). This can impact future pregnancies adversely, heightening risk 
for preeclampsia and gestational diabetes, but can also impact long-term health status 
after pregnancy. Women who failed to lose the weight gained during gestation enter 
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menopause at a higher risk for experiencing cardiovascular disease, insulin resistance, 
and with increased fat mass compared to lean mass (35-36).  
1.2 Adipose Tissue Physiology 
White adipose tissue is the primary vehicle for storage of energy by the body. It 
can be divided into two categories- subcutaneous, which lies beneath the skin and serves 
a protective role and visceral, which infiltrates deeper in the body to surround the viscera 
and metabolic organs. White adipocytes are characterized by large unilocular lipid 
droplets which can communicate systemically with other organs as mobilization and 
storage of energy occurs, making adipose a complex and dynamic organ that responds 
actively to environmental stimuli.  
Adipose tissue has two core mechanisms for maintaining adequate energy 
storage: hyperplasia and hypertrophy. Hyperplasia is the differentiation of new 
adipocytes from precursor cells. This function primarily occurs in early development and 
is localized to the subcutaneous fat depot, however ongoing research has identified that 
high fat diet feeding and diet induced obesity may trigger the proliferation of new 
adipocytes for expansion of white adipose tissue in a PI3K-AKT pathway dependent 
manner (37). An emerging phenotype of obesity, the “metabolically healthy obese” is 
also thought to have adipose depots with higher rates of hyperplasia and a lower ratio of 
lipid to cell as compared to traditional models of obesity, indicating that hyper-plasticity 
of adipose tissue may play a protective role. 
Hypertrophy is the expansion of adipocytes with excess lipid. Hypertrophic 
adipocytes are classically associated with obesity and typically have three identifying 
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attributes in addition to their increased size: necrosis, increased secretion of 
inflammation promoting molecules and macrophage recruitment, and insufficient 
vasculature.  Hypertrophy has been implicated as a risk factor for insulin resistance, non-
alcoholic fatty liver disease and cardiovascular disease (20).  
1.3 Cell Signaling Involved in Fat Deposition 
1.3.1 AKT 
Protein Kinase B, also referred to as (AKT) is a critical component of cellular 
synthesis pathways, insulin signaling and cellular growth via protein synthesis. AKT1 is 
largely involved in cellular growth and homeostasis. AKT2 is the isoform that plays a 
primary role in insulin signaling due to high affinity binding with phosphoinositides, 
specifically PIP2 or PIP3. The AKT3 isoform is has the lowest expression and is 
typically only active in relation to neuronal development (38). AKT requires 
phosphorylation by phosphoinositide-domain-kinase 1 (PDK1) at Thr308 and PDK2 has 
been postulated to phosphorylate Ser 473, which is the component that provides 
stabilization during activation (39). Depending on level of expression, AKT can have 
potent implications for metabolism and cellular regulation. Downregulation of AKT has 
been shown to influence development of diabetes and aberrant insulin signaling.  
Tumor Necrosis Factor alpha (TNF-α), which is largely associated with 
inflammatory response, also acts on active, phosphorylated AKT and its downstream 
target PI3K. In doing so, ability to phosphorylate Insulin Receptor Substrate 1 (IRS1) is 
inhibited, leading to dysfunctional insulin signaling (40-41).  
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1.3.2 AMPK 
AMP- activated protein kinase complex is composed of three subunits α, β, and 
γ, each with distinctive roles. The β and γ subunits are primarily responsible for 
identifying shifts in ratio of AMP:ATP in times of reduced energy availability, with the 
β unit sensing available glycogen stores (42.) This subunit is composed of four distinct 
CBS domains that create two sites in which AMP can bind, in turn exposing the catalytic 
domain of the alpha subunit. Phosphorylation of the alpha subunit activates AMPK 
activity (43). During periods of low energy or hypoxia, AMPK inhibits cell growth by 
inhibiting mTOR complex 1, but also increases levels of autophagy to ensure that the 
body has sufficient nutrients available (44). AMPK also plays an important role in 
regulating lipid metabolism and glycolysis through phosphorylation and consequent 
inactivation of Acetyl CoA Carboxylase and suppression of Malonyl CoA levels which 
leads to increased transit of fatty acid for mitochondrial oxidation through CPT1. 
Phosphorylation and consequent downregulation of AMPK is influenced by high levels 
pro-inflammatory cytokines Tnf-α, Il-6 and Il-1β, whereas inactive AMPK plays an anti-
inflammatory role that may be associated with Il-10 expression (44).  
1.4 Key Modulators 
1.4.1 Ppar-γ and C/ebpα 
Ppar-γ and C/ebpα are considered to work in tandem as the primary regulators of 
adipogenesis. These two components rely on each other to execute the critical roles in 
the terminal stages of adipogenesis and allow for transcription of adipogenic genes (45). 
In cell studies and animal models, Ppar-γ has proved to be the driving force of terminal 
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adipogenesis, working with Fatty Acid Binding Protein 4 to recruit lipid into adipocytes. 
Knockdown models of c/ebpα result in overcompensation of Ppar-γ to continue 
adipogenesis, however complete knockout models of c/ebpα results in an inability of 
adipocytes to develop and form white adipose tissue, as well as an inability of the liver 
to perform gluconeogenesis indicating the essential role of both Ppar-γ and c/ebpα as a 
functional unit for adipogenesis (46).  
1.4.2 Srebp1c 
Srebp is a family of three isoforms Srebp1a, Srebp1c and Srebp2. Srebp1a is 
involved in multiple pathways including cholesterol and triglyceride synthesis, whereas 
Srebp1c and Srebp2 are more transcriptionally limited to fatty acid synthesis (47).  
Srebp1c is involved in sterol biosynthesis as well as LDL and fatty acid synthesis. 
Srebp1c is highly expressed in adipose tissue and influences adipocyte differentiation by 
acting upon Ppar-γ and c/ebpα, although the complete mechanism for this action is 
unknown (48). In mouse models, overexpression of Srebp1c results in lower levels of 
white adipose tissue, but significant infiltration of fatty acids into the liver and other 
tissues, which may influence development of lipotoxicity (49).  
1.4.3 Acacβ 
Acetyl-CoA Carboxylase has two distinct isoforms Acc1 (acaca) and Acc 2 
(acacβ). Acc1 is involved in commitment of fatty acid synthesis by catalyzing the 
conversion of Acetyl CoA to Malonyl-CoA. (50). During times of low energy, Acc1 is 
phosphorylated and inactivated; a function that can be executed by AMPK to limit 
synthesis of fatty acids. In contrast, Acc2 promotes beta oxidation of fatty acids. Total 
 11 
 
knockout models of Acc2 in mice display reduced fat mass and increased levels of fatty 
acid oxidation, which has potentiated the role of Acc2 in future pharmaceutical 
interventions of obesity (51).  
1.4.4 Fasn 
Fatty Acid Synthase is a complex composed of multiple enzymes which plays a 
primary role in synthesizing long chain saturated fatty acids such as palmitate, in the 
presence of Acetyl CoA and Malonyl CoA. Fasn is expressed predominately in the liver, 
concordant with the high level of lipogenic activity that occurs there. However, in 
obesity, Fasn expression is increased in visceral adipose tissue and the liver and 
contributes to increased rates of adipogenesis. Fasn has been implicated as a driver of 
obesity, and its upregulation in adipose tissue has been correlated with hyperinsulinemia 
and dyslipidemia in human patients (52).  
1.4.5 CD36 and Fabp 
CD36, also referred to as fatty acid translocase is a membrane bound protein that 
has lipid specific scavenging properties. CD36 is expressed in differentiated adipocytes 
and is partially responsible for uptake of oxidized LDL and long chain fatty acids (53).  
In models of CD36 deletion, there is a simultaneous decrease in fatty acid uptake and 
increases in circulating level of plasma triglycerides and insulin sensitivity in muscle 
tissue, indicating its role in metabolic homeostasis and fatty acid utilization.  
CD36 is expressed in a variety of tissues. CD36 expression on monocytes is 
correlated with increased digestion of pro-apoptotic cells which is hypothesized to play a 
significant role in triggering signaling of fibrotic pathways (54).  
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Fatty acid binding protein (FABP) has many isoforms functioning throughout the 
body. The adipocyte specific protein FABP-4, or AFABP, functions in tandem with 
CD36 to transport lipid into cells. AFABP expression increases during lipogenesis and 
during consumption of high fat diet, indicating its role in lipid transport (55).  
1.5 Obesity as a Disease of Inflammation 
1.5.1 Triggers of Inflammation 
Adipose tissue has the capacity to initiate and respond to local and systemic 
inflammation by secreting cytokines, adipokines and activating macrophage response. In 
pregnancy, adipose tissue plays a critical role in evolving the innate and adaptive 
immune response of the developing fetus, by communicating with the placenta (56). In 
obesity afflicted pregnancies, the onslaught of pro-inflammatory molecules can 
negatively affect fetal growth and developmental outcomes and increases maternal risk 
of miscarriage, preeclampsia, and gestational diabetes. Visceral adiposity induced by 
high fat diet plays a role in both central and peripheral inflammation. Wild type mice 
that were recipients of GFP-positive mice donor bone marrow transplants fed high fat 
diet for 15 or 30 weeks had increased adipocyte hypertrophy and adipose tissue 
inflammation, but also had increased recruitment of bone marrow derived leukocytes in 
the central nervous system, which induced inflammation (57). 
In regard to obesity induced inflammation, two primary theories exist as to what 
serves as the initial trigger of this occurrence: hypoxia, and lipotoxicity. 
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1.5.1.1 Hypoxia 
Rapid expansion of adipose tissue results in decreased blood flow and 
consequently limited transportation of oxygen. Studies have indicated that a concurrent 
increase in angiogenesis and angiogenic gene expression needs to occur to enhance 
expansion of adipose tissue. Obese subjects fail to have the associated angiogenic 
response post prandially as compared to lean subjects characterized by reduced 
vascularization and decreased transcription levels of angiogenic genes (20). In mouse 
studies of wildtype vs ob/ob mice, levels of adipose tissue oxygenation were 
significantly lower in obese mice consistent with measurements of tissues which operate 
in a hypoxic state such as the retina (58). Hypoxia has significant metabolic 
implications, as it results in lowered levels of oxidative phosphorylation, to conserve 
oxygen, and the increase in GLUT translocation to compensate for upregulated 
anaerobic glycolysis. Altered oxidative phosphorylation in the mitochondrial may result 
in generation of reactive oxygen species which may further enhance local inflammation 
(59).  
1.5.1.2 Lipotoxicity 
Obesity strains adipose tissue to store an excess of energy. Due to the unilocular 
nature of adipocytes, some researchers have theorized that individual adipocytes have a 
threshold capacity for storage of lipid. Burden to expand beyond this threshold results in 
structural failure of the cell and spillage of free fatty acid into surrounding 
compartments. Concurrent with “lipid spillage” there is a reduction in fatty acid 
transport to adipose tissue, decreased ability to form new adipocytes to accommodate 
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storage demand, and increased trafficking of fatty acids to non-adipose tissues such as 
muscle and liver (20,60). Metabolic complications of lipid toxicity are primarily seen in 
development of conditions effecting other organs such as non-alcoholic fatty liver 
disease, however lipotoxicity can also result in increased recruitment of macrophages 
(61), which will be discussed in the next section. 
1.6 Macrophage Function and Interaction with Adipocytes 
Healthy adipose tissue is equipped with resident macrophages which assist with 
clearance of dead cells and cellular debris through phagocytosis, which helps ensure 
proper turnover and health of tissue. Macrophages can also buffer lipolytic activity by 
preventing excessive lipid release into the bloodstream, ensuring metabolic homeostasis 
remains intact. These macrophages are broadly referred to as M2 macrophages or 
alternatively activated macrophages due to their “anti-inflammatory” properties (60).  
Under conditions of obesity and high fat feeding, adipose tissue has a marked 
increase in both number and type of macrophages in visceral adipose tissue, in both 
human and mice models. Obesity induced inflammation and mitochondrial stress can 
result in cellular damage and consequent spillage of lipid droplet into surrounding tissue, 
or lipotoxicity. This stimulates macrophage response for containment of lipid spillage, 
resulting in pockets of macrophage accumulation called crown like structures (CLS) 
(62). Macrophages recruited for inflammatory response undergo a phenotypic switch, 
from M2 to M1 or “classically activated”, which is considered to be significantly more 
inflammatory. Pro-inflammatory macrophages, or M1 macrophages, induce cellular 
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apoptosis, monocyte-derived macrophage recruitment and expression of cytokines Il-6, 
Il-1β  and Tnf-α.  (63-64).  
 Multiple studies have indicated that macrophages present in adipose tissue from 
HFD obesity have different characteristics from their lean counterparts in regard to fat 
metabolism and secretion of pro-inflammatory cytokines (60, 65-66).  One such 
macrophage is CD68+, a M1 macrophage, which is identified by either F4/80 in mice or 
EMR1 in humans. These identifiers are cell-surface glycoprotein markers of bone 
marrow derived macrophages (66) present in obese adipose tissues.  Increased presence 
has been associated with HFD intake and endotoxemia in obese pregnancies (67). 
For example, a classification of placentas from obese mothers noted a fourfold 
increase in inflammation induced insulin resistance, and a significant heterogenous 
increased in resident CD68+ macrophages versus placentas from lean mothers (68). 
Given the role that the placenta has in maternal-fetal interface, increased presence of 
pro-inflammatory macrophages can be a strong indicator of a dysregulated inflammatory 
phenotype.  
1.7 Important Cytokines Involved in Inflammation 
1.7.1 Il-6 
Il-6 is synthesized quickly and efficiently in response to tissue damage, infection 
and injury through its receptor complex with GP130. GP130-Il6 complex activates 
signaling pathways of inflammation such as Janus Kinase (JAK/STAT), and PI3K (69). 
Cytokines Il-6, Il-1β and Tnf-α function together to trigger neutrophil accumulation in 
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times of acute inflammation. The increased density of neutrophils activates Il-6 trans 
signaling which leads to tissue specific chronic inflammation (70).  
1.7.2 Il-1β 
Il-1β is largely produced by activated monocyte derived macrophages, similar to 
those found in adipose tissue. Il-1β  is essential for acute phase response of 
inflammation, and signals for production of acute phase reactants like C-reactive protein 
in the liver. Autophagy is a critical physiological function which breaks down cellular 
components to provide energy in times of depletion, such as during fasting or extended 
exercise. Il-1β interacts within autophagosomes to promote macrophage recruitment in 
the liver and adipose tissue.  When pathways of autophagy are not activated, Il-1β is then 
secreted from the autophagosome to trigger an external inflammatory effect. This 
relationship has furthered research into Il-1β’s role in apoptosis and how its release may 
be a committed signal for cell death, however this work is still ongoing (71). 
1.7.3 Tnf-α 
Tnf-α is predominantly secreted from macrophages, rather than adipocytes. Tnf-α 
overexpression as a result of inflammation can activate adipocyte insulin resistance. The 
cytokine can phosphorylate the serine residue on both Insulin receptor and Insulin 
Receptor Substrate 1, which tamps down activity of PI3K and may influence AKT 
activity. Tnf-α is also a potent regulator of NF-κB and JNK signaling pathways (72). 
1.7.4 Il-10 
Contrary to the aforementioned cytokines, Il-10 is frequently classified as anti-
inflammatory. Il-10 plays an essential role in maintaining inflammatory homeostasis by 
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mitigating cellular response to exaggerated inflammation.  After HFD feeding, increased 
expression of Il-10 in adipose tissue has been correlated with presence of M2 
macrophages that remains elevated even when insulin sensitivity is maintained (73). 
Suppression of Il-10 can result in increased infection, chronic inflammation and chronic 
disease such as inflammatory bowel disease, asthma and systemic lupus erythematosus 
(74). 
1.8 Cell Signaling for Inflammation 
1.8.1 NF-κB 
NF-κB is a vital factor in systemic response to inflammation, as well as adaptive 
and innate immunity. NF-κB has been characterized as a quick response in presence of 
deleterious cellular stimulation such as reactive oxygen species. Two critical activators 
of NF-κB response are the pro-inflammatory cytokine Il-1β and Tnf-α. Induction of NF-
κB response is controlled primarily through two pathways: canonical and alternative. 
Function of the canonical pathway is dependent upon the degradation of the inhibitory 
component IκB. NF-κB’s inhibitory component, identified as IκB1 or IκB2 is prone to 
phosphorylation and consequent degradation by key stimuli such as reactive oxygen 
species and proinflammatory cytokines Il-1β and Il-6 (75). Translocation of NF-κB to 
the cell nucleus results in elevated inflammatory status and insulin resistance which has 
been seen in murine knockout models of hepatic and skeletal IκB1 (40,63). Alternative 
activation occurs through production and phosphorylation of the protein p100 as a result 
of activation to NF-κB inducing kinase (NIK). Both pathways contribute significantly to 
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the role of NF-κB in inflammation, especially in relation to obesity, chronic disease, and 
cancer.  
1.8.2 JNK 
Cellular stress caused by reactive oxygen species (ROS), DNA damage and pro-
inflammatory cytokines initiates cellular death pathways of apoptosis in order to 
maintain health and integrity of undamaged cellular components. C-jun-n terminal 
kinases, also known as JNK or stress-activated protein kinase (SAPKs) are integral 
components in cellular apoptosis, inflammatory response, and production of cytokines. 
The JNK family operates closely with mitogen activated protein kinases, specifically 
MAP3K and MAP4K, which become activated in response to transmitted stress signals 
from receptor associated membrane alterations (76). Universally expressed JNK1 and 
JNK2 are both activated by phosphorylation and translocation to the nucleus, where they 
can associate with and activate a range of factors such as C-Jun and the p53 pathway 
which are involved in upregulation of apoptosis, or downstream with inhibitors of cell 
survival. The Janus Kinase family (JNK1, JNK2, and JNK3) have been seen to be 
upregulated under chronic inflammatory conditions. During early development, 
lipotoxicity resulting from increased free fatty acids in the bloodstream of obese women 
has been associated with placental dysfunction and generation of reactive oxygen species 
associated with activation of the JNK pathway (77). 
 
 
 
 19 
 
1.9 Maternal Diet Intervention 
1.9.1 Human Study 
The proportion of overweight and obese women of childbearing age in the united 
states has risen to a staggering number, necessitating effective intervention with long-
term adherence. Previously, work has been focused on preventing malnutrition and 
nutrient deficiencies that are associated with restricted infant growth and birth defects.  
With the rise of enriched and fortified foods, as well as better understanding of the 
effects of gestational malnutrition, concern has shifted to the consequences of 
overnutrition. Gestation based intervention is challenged by potential consequences to 
fetal growth restriction and complications of extracting true physiological changes 
brought upon by intervention rather than physical metabolic and hormonal alterations 
that occur during pregnancy (78).  
Researchers have structured intervention protocols with minimally invasive 
techniques such as water aerobics, specialized physical training sessions, nutrition 
coaching with registered dietitians, and adherence to Institute of Medicine guidelines for 
gestational weight gain (79-80). Outcomes have been varied. Many groups have seen 
little to no improvements in maternal weight control or reduced diagnosis of 
preeclampsia and gestational diabetes whereas some groups have seen only slight 
reductions in preventing large for gestational age babies. While these studies provide 
important attempts at prevention, they still lack conclusive and significant results that 
can contribute to developing treatment plans for overweight and obese mothers that can 
also impact offspring health.  
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1.9.2 Mouse Study 
In mouse studies, offspring outcomes have been effectively rescued by maternal 
diet intervention. A study conducted by Zambrano et al. (81) compared offspring 
outcomes of pups born to either dams with maternal obesity induced through high fat 
diet, or dams who underwent maternal diet intervention to a chow diet one month prior 
to gestation. Offspring born to obese mothers experienced increased levels of serum 
triglycerides, leptin, insulin resistance, fat mass, and adipocyte size that was either 
partially or fully recovered by maternal diet intervention. Additionally, a study which 
evaluated how maternal diabetes impacted cellular stress and apoptosis in murine 
embryos noted that intervention with metformin in the drinking water of dams alleviated 
embryonic stress, glucose intolerance, insulin resistance and reduced apoptosis (82).  
Previous work from our lab has indicated that a maternal short-term dietary 
transition prior to pregnancy (1 week) significantly exacerbated dysregulated insulin 
signaling and glucose tolerance in both hepatocytes and adipocytes, more so than 
treatment with HFD alone in female offspring (83). The early onset of symptoms in our 
mice, independent of maternal glucose intolerance or obesity, prompted the question as 
to how this maternal diet transition time point may contribute to in utero metabolic 
programming, as well as whether longer gaps in transition prior to gestation may play a 
feasible role in reducing metabolic complications in offspring.  
These studies illustrate the impact that maternal diet intervention can have on 
reducing or exacerbating negative offspring outcomes. High fat diet intake, excessive 
circulating energy in utero and maternal obesity have all been implicated in triggering 
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oxidative and cellular damage, which increases pro-inflammatory signaling cascades. 
Reducing offspring adiposity might be an essential mechanism to decrease inflammation 
and maintain metabolic homeostasis.  
1.9.3 Overcoming Barriers 
Gaps in knowledge still exist as to timing of maternal intervention, ideal dietary 
composition, lifestyle changes prior to conception and planning long term adherence. 
Creating a framework in which health professionals can tackle the diverse issues 
surrounding the underlying causes of obesity in a manner that is sustainable and 
effective to patients is critical to ensuring health of future generations. Maternal 
inflammation, BMI and gestational weight gain are critical factors that influence 
development of offspring obesity (84). Our research is focused on contributing an 
expanded understanding of systemic inflammation associated with obesity in offspring, 
which is critical for mitigating poor outcomes and engaging targeted treatment options. 
Currently, no concrete recommendations exist as to when specific diet intervention 
should begin to ensure positive outcomes for both mother and baby. Establishing 
specific timelines to follow is an important step in closing the current gap in patient care. 
This research aims to lay a framework for identifying important transition points which 
discourage onset of disease for future offspring, providing better quality of life and 
enhanced quality of care. Elucidation of key regulatory mechanisms and modeling of in 
utero programming provides more advanced knowledge about obesity and development, 
therefore offering opportunity at success when applied in future clinical trials. 
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CHAPTER II 
HYPOTHESIS AND SPECIFIC AIMS 
 
 
2.1 Overall Hypothesis 
Different transition period of maternal diet intervention differentially impacts metabolic 
and inflammatory complications in male mice offspring induced by maternal high fat diet.  
2.1.1 Specific Aim 1 
To determine if and how different durations of intervention in maternal diet prior 
to pregnancy affect physical attributes of obesity and indicators of adipogenesis. Based 
on previous work from our lab (83), I hypothesize that a long-term, but not a short- or 
medium-term, diet intervention will allow for recovery of offspring from development of 
obesity and improved adipose tissue function. I will evaluate differential effects on male 
offspring adiposity by evaluating physical indicators of adiposity such as ratio of fat to lean 
mass, adipocyte diameter, and body weight (Aim1a), and cellular control of adipogenesis 
and lipogenesis by evaluating genes regulating fatty acid transport and metabolism 
(Aim1b). 
2.1.2 Specific Aim 2 
Identify how important signaling mechanisms underlying chronic inflammation in 
visceral white adipose tissue are affected by different durations of maternal diet 
intervention.  I hypothesize that a long-term transition will be protective from over-
activation of adipose inflammation and macrophage infiltration in offspring. I will evaluate 
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cellular characteristics of adipose tissue inflammation such as percent infiltration of F4/80 
macrophages, presence of crown like structures and Il-6, Il-1β and Tnf-α cytokine 
expression. I will further evaluate the JNK and NF-κB signaling cascades which have been 
identified as critical underlying mechanisms in establishing chronic systemic inflammation 
in obesity, to determine if activation of these pathways is altered in response to maternal 
diet. 
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CHAPTER III 
 MATERIALS AND METHODS 
 
Female C57/BL6J mice, 12 weeks of age, were selected for study and assigned 
either a normal fat diet (10% kcal from fat) or a high fat diet (60% kcal from fat), which 
was adhered to for 12 weeks. Breeding pairs administered a high fat diet continued this 
diet through gestation and lactation or were transitioned to a normal fat diet at either a 
one-week, five-week or nine-week time window prior to pregnancy followed through 
gestation and lactation. Male mice offspring were selected for their distinct obesogenic 
phenotype upon treatment with HFD. From each litter, a minimum of two male mice 
were randomly selected, with a minimum of three distinct litters being involved in each 
treatment group. A separate group, birthed of the breeders who adhered to the NF diet, 
were continuously fed the NF diet through 12 weeks, and utilized as a reference control 
group (Figure 1). All other offspring were given a high fat diet for 12 weeks after 
weaning, to promote weight gain before their consequent sacrifice. Mouse experiments 
were completed according to a protocol reviewed and approved by the Institutional 
Animal Care and Use Committee of the University of North Dakota and Texas A&M 
University, in compliance with the USA Public Health Service Policy on Humane Care 
and Use of Laboratory Animals. 
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Figure 1: Study Design 
 
 
Diet was purchased from Research Diets, LLC (New Brunswick, NJ). The 
normal fat diet (Cat#D12450B) had an energy density of 3.771 kcal/g (10% fat energy, 
70% carbohydrate energy, and 20% protein energy). The HF diet (Cat#D12492) had an 
energy density of 5.157 kcal/g (60% fat energy, 20% carbohydrate energy, and 20% 
protein energy). The fat source is composed of 92% of lard and 8% of soybean oil.    
 Mice remained singly housed throughout the study and were weighed once per 
week. Energy consumption was calculated each week. Both logs were tracked 
throughout the 12-week post-weaning HFD feeding portion of the study. After the 12-
week timepoint concluded, mice were humanely sacrificed with CO2 asphyxiation 
followed by cervical dislocation. Fat pads were excised from the visceral region and 
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weighed immediately, before being equally divided for two tubes and snap frozen in 
LN2. Fat pad mass was normalized against individual murine body weight. 
Dissected adipose tissue samples of ~1mm were fixed overnight in 10% formalin 
at 4o Celsius. Tissues were washed briefly in PBS to remove excess formalin and placed 
into cassettes for processing. Cassette sections were dehydrated in increasing 
concentrations of Flex-100 and Xylene and then impregnated with paraffin wax 
overnight. Sections are fixed in molds with paraffin wax and sliced using a Leica 
Microtome into 5um sections. Tissue sections were mounted on noncharged microscope 
slides. Slides were stained with Harris-modified Hematoxylin and Eosin-Y solution 
(alcoholic with phloxine), dried overnight, and mounted with slide-glass using 
Paramount (85). Microscopy was performed using a Leica D2500 microscope at 10X 
and 20X magnification. For cell diameter measurement, 100 cells were counted from 2 
distinct images (200 cells total/per sample) at 100x magnification using the crosshairs 
diameter and quantification tool of the Fiji plugin of ImageJ software (NIH). All 
measurements were taken in units of micrometers.  
To determine percent area occupied by crown like structures, each image was 
converted to 8-bit, with a threshold applied to highlight area occupied by crown like 
structures, which was subtracted from total image area to determine percent area Fiji 
plugin of ImageJ. Images containing large white or blank spaces were not used to ensure 
there was no size bias in measurement. Two images from each sample, n=4-6 per group, 
were utilized for measurement. Data reported as average % area. 
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Adipose tissue sections used to determine F4/80 area were mounted on Bond 380 
noncharged microscope slides underwent progressive deparaffinization in Xylene and 
rehydration in serial dilutions of Ethanol. Antigen retrieval was completed using a 
modified vegetable steamer  and a coplin jar of sodium citrate buffer (Na3Citrate 10mM, 
0.05% tween 20, pH6.0) for 25 minutes, followed  by cooling time and quenching of 
endogenous peroxidase activity with 3% H2O2. VecStain ABC anti-goat reagent kit 
(Vector Laboratories) will be utilized for the serum, secondary antibody incubation and 
ABC reagent. Anti-Goat serum will be incubated for 30 minutes at room temperature 
followed by overnight incubation of F4/80 antibody (Cell Signaling Technology) in a 
1:1000 dilution at 4o Celsius. ImmPACT DAB peroxidase substrate kit with chromogen 
(Vector Laboratories) will be utilized for staining of F4/80 with Mayer’s modified 
hematoxylin used as a counterstain. Analysis will be performed on a color isolated 
threshold scale using Fiji plugin of Image J (NIH).  
Adipose protein was consequently extracted to execute western blot analysis. 
Approximately 3-5mg of visceral adipose tissue was dissected from total sample, on ice, 
and placed into a 2.0 mL tube with 200uL RIPA buffer, 50uL Pierce phosphatase 
inhibitor, and 50uL dissolved Complete Ultra EDTA tabs. Tissue was homogenized on 
ice using a Homogenizer150 (Fisherbrand) and then left to lyse for 15-30 minutes. 
Samples were then centrifuged for 30 minutes at 10000 RPM at 4o Celsius. Ultra thin 
pipette tips, were used to extract the protein layer cleanly from underneath the lipid disk. 
Samples were centrifuged for 5 minutes at  4o Celsius, to ensure no remaining lipid had 
contaminated samples.  
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Protein concentration was determined using a Pierce BCA kit (ThermoFisher). 
All samples were completed in triplicate and normalized to a standard curve. Protein 
concentration was finalized by identifying which sample contained lowest concentration 
and diluting all running samples to the same level for standardization. Respective 
concentrations of protein, water and Laemmli loading dye, were boiled for 5 minutes at 
95o C, vortexed and centrifuged before use. Ten-well agarose gels (7.5%) were utilized, 
with one lane occupied by ladder and the remaining 9 lanes occupied by sample (3 
groups per gel with 3 samples/group). Gels were transferred to PVDF membrane using a 
Biorad TurboBlot transfer system for 45 minutes at 25aV at 4o C. Membranes were then 
blocked in a solution of 5% Bovine Serum Albumin and then incubated for 24-48 hours 
in respective primary antibody (dilution 1:1000) at 4o C (See appendix 1 for list of 
antibodies). Membranes were washed in TBST 3x10min, incubated with secondary 
antibody (HRP linked anti—rabbit), washed again in TBST 3x10min, and then imaged 
using ECL reagents (Millipore) and a Biorad Chemidoc imaging system. Protein 
quantification was executed utilizing Fiji Plugin of ImageJ software (NIH) and 
standardized against home-keeper protein GAPDH.  
To determine gene expression, we next completed QPCR by first extracting 
adipose tissue RNA. Adipose tissue samples of approximately 150-200mg were 
homogenized in approximately 500ul of Trizol on ice in RNASE free tubes. Samples 
were incubated for 5 minutes at room temperature. Approximately 100ul of chloroform 
was added and samples were shaken vigorously. Samples were again incubated at room 
temperature and then centrifuged at 12000RCF for 15 minutes at 4o C. The supernatant 
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was transferred to a new tube with and equal volume of  isopropanol vortexed to mix. 
Samples were incubated again for 10 minutes and then centrifuged at 12000RCF for 10 
minutes at 4o C. This was repeated twice to clean samples and then the final supernatant 
was removed and the pellet was left to dry in a ventilation room for 5 minutes. RNA 
concentration was quantified using a Nano Drop 2000. RNA levels were standardized 
with DDH2 O to 0.5ug/ul.  
cDNA synthesis was completed in 0.2mL tubes utilizing 1uL of RNA template 
(total RNA concentration 1ug), 15uL RNASE/DNASE free water and 4 uL of 
readyscript cDNA synthesis mix. Mixture was vortexed, centrifuged and then incubated 
in a thermocycler (Eppendorf) for 5 minutes at 25o Celsius, 30 minutes at 42o Celsius, 5 
minutes at 85o Celsius and then held at 4o Celsius before storage at -20o Celsius. Plates 
with 384 wells were run on a BioRad plate reader under the following conditions: Step 1 
95°Celsius 10 min for initial denaturation of target DNA followed by 40 cycles of steps 
at 94°Celsius, 58°Celsius, and 72°Celsius, with fluorescence data collection at each 
58°Celsius cycle end.  
All data was measured through statistical analysis. Measurements for single time 
points were analyzed by Fishers’ least significant difference test so multiple comparisons 
of differences between groups REF, NF, HF, H1N, H5N and H9N were considered. 
Fisher’s least significant difference test was performed by first carrying out one-way 
analysis of variance for all treatment groups. For the longitudinal data such as body 
weight and food consumption, a linear mixed model was used for the analysis of 
repeated measures with each individual mouse as a random effect. For QPCR data, 
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reported fold change was calculated using the delta method (86). Values that were 
significantly different (p<0.05) from the NF group are indicated with a * sign, whereas 
all values significantly different from the HF group are indicated with a # sign. 
Adipocyte diameter, F4/80 quantification, and CLS calculations were compared using a 
Fisher’s least significant difference using one-way analysis of variance. All analyses 
were carried out by using SAS JMP software (SAS Institute Inc., Cary, NC, USA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 31 
 
CHAPTER IV 
RESULTS 
 
Initially, postnatal energy intake was determined to determine differences 
between groups. The REF group had the lowest postnatal energy intake, correlating with 
its adherence to the NF diet. There was no significant difference in energy intake 
between the other groups reflected by their adherence to HFD (Fig 2A), indicating that 
offspring energy consumption was not dependent upon maternal transition time.  
At birth there was no statistically significant difference between body weight in 
all groups. The REF group maintained the lowest body weight throughout the 12-week 
postnatal timepoint, correlating with continued adherence to the NF diet. The NF group 
was slightly but insignificantly elevated as compared to the REF group. The H5N group 
maintained postnatal weight similar to the NF group and had no significant difference 
when compared to either the NF or REF group. Both the HF and H9N maintained 
similar body weights throughout the 12-week postnatal period and were elevated 
compared to the H5N group. Both HF and H9N had significantly increased body weights 
compared to the REF group at week 12. The H1N group deviated in body weight 
beginning at week 5 and maintained a consistent and significant increase in body weight 
compared to all other groups (Fig 2B). The increased body weight observed in the H1N 
group did not correlate with a concurrent increase in caloric intake, indicating that the 
increased body weight was influenced by maternal transition.  
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To evaluate how maternal diet effected visceral adiposity, we next measured 
amounts of visceral adipose mass compared to overall body weight (Fig 2C). The H1N 
group had the highest level relative adipose tissue when visceral adipose tissue mass was 
normalized against total murine body weight. The relative adipose tissue of the H9N 
group was significantly reduced compared to the H1N group, although it remained a 
significantly higher level than that of the NF group. In contrast, while the H5N group 
had significantly reduced relative adipose tissue mass compared to the H1N, H9N, and 
HF groups, it was still higher than the REF group (Fig 2C).  
Glucose tolerance was measured by performing IPGTT before termination at 
week 12. Glucose tolerance was determined by evaluating the area under the curve 
(AUC). Fasting glucose was not significantly different between groups. All groups 
peaked at approximately 30-60 minutes and were able to return to basal level at 120 
minutes with the exception of the H5N group. The NF and HF groups were glucose 
tolerant at week 12 (Fig 2D and E). The H9N group was not statistically different from 
the REF group and displayed recovered glucose tolerance compared to the H5N and 
H1N groups. The H1N and H5N groups displayed significant glucose intolerance 
(p<0.01), as compared to the REF group, however the H1N group was able to return to 
basal glucose levels after 120 minutes. 
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Figure 2- Offspring Energy Intake, Weights and Glucose Tolerance 
Legend: (A) Energy intake of the male mice from wean until week 12 showed 
significantly lower consumption of energy in REF group-the only postweaning group 
administered NF diet. (B) Body weight of male offspring from wean to week 12. (C) 
Visceral adipose tissue mass was normalized against individual murine body weight to 
eliminate outliers. Different letter indicates significance level of p<0.05 between any 
two groups. (D) IPGTT at week 12, H1N and H5N group had impaired glucose 
tolerance. (E) H1N and H5N had significantly increased AUC (p<.01) as compared to 
other groups. All Figure 1 data is reported as Mean±SEM, (n=6-10). 
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Adipocyte diameter was normalized against the REF group to determine how 
different duration of maternal diet intervention effected adipocyte size. When compared 
to the NF offspring, the H1N offspring had significantly increased adipocyte diameter, 
however this was not significant in relation to any other group. The H5N group also 
experienced significantly increased adipocyte diameter when compared to the HF group. 
Although the H9N group had similar adipocyte diameter compared to H5N, there was a 
slight reduction in adipocyte size which resulted in no significant difference between 
H9N offspring and any other offspring groups (Fig 3).  
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Figure 3- Visceral Adipocyte Diameter 
Legend: (A-F) HE staining of visceral adipose tissue. (G) Cell diameter measurements of 
adipocyte normalized against REF group (n=5-7 ± SEM).  
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Ppar-γ expression is highly correlated with adipocyte differentiation and is a 
facilitator for fatty acid and glucose uptake (87). The H1N group experienced significant 
increase in expression of Ppar-γ and C/ebpa , as did the HF group, when compared 
against the NF group. The high expression of Ppar-γ in the H1N group correlates with 
the increased fat mass and adipocyte diameter measured in this group, indicating a 
preferential uptake of excess energy in this group. In contrast, the H5N group has 
significant reduction in expression of Ppar-γ compared to the HF group, although there 
is a significant increase in levels of  C/ebpa. Reduced expression of Ppar-γ may explain 
the increased glucose intolerance experienced by the H5N group, however the increased 
expression of C/ebpa may partially explain why the H5N group maintains significantly 
increased adipocyte diameter, given its role in terminal adipocyte differentiation. In 
contrast the H9N group maintains expression levels of both genes similar to the NF 
group and has significantly lowered expression when compared to the HF group (Fig 4 
A&B).  
Srebp1c is highly expressed in adipose tissue and influences adipocyte 
differentiation by acting upon Ppar-γ (48). Srebp1c was significantly overexpressed only 
in the HF offspring when compared to the NF offspring. There was no significant 
difference between H1N, H5N and H9N offspring who all had expression levels similar 
to the NF offspring (Fig 4C).  Acacβ and Fasn are two genes encoding two rate-limiting 
enzymes for fatty acid synthesis. Fasn was significantly increased in the HF, H1N and 
H5N offspring as compared to the NF group. The H9N group had significantly 
decreased expression when compared to the HF offspring and was expressed similarly to 
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the NF offspring (Fig 4D). Expression levels Acacβ were significantly increased in the 
H1N and HF offspring compared to the NF offspring. The H5N and H9N groups had 
reversed expression similar to the NF offspring (Fig 4E).  
We further measured the expression of genes in fatty acid transport in adipose. 
CD36 levels were significantly increased in the HF and H5N groups as compared to the 
NF group, whereas H9N was significantly decreased compared to the HF group. The 
H1N group had a similar level of CD36 as the NF group.  Additionally, Fabp-4 
overexpression occurred significantly in the HF, H1N and H5N groups compared to the 
NF group. When compared to the HF offspring, the H9N offspring had significant 
reduction in expression, similar to the NF offspring. 
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Figure 4-Genes of Adipogenesis  
Legend: (A-G) The adipose tissue expression of Ppar-γ, C/ebpa, Srebp1, Fasn, Acacβ, 
CD36, and Fabp4 were measured by real-time PCR. The expression level was 
normalized against the NF group. Data is reported as Mean±SEM, n=3-5. The “*” 
symbol indicates p<0.05 versus the NF group. The “#” symbol indicates p<0.05 versus 
the HF group.  
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CLS are pockets of lipid spillage resulting from cellular or oxidative damage to 
adipocyte cell membranes. Presence of CLS was not significantly different among the 
NF, HF, H1N or H5N groups. The H9N group on the other hand had a significantly 
decreased presence of CLS compared to both the HF and NF groups, indicating a 
recovery of inflamed phenotype (Fig 5 A, C).  
F4/80 is indicative of activated macrophage presence in adipose tissue (82). The 
H1N and HF group had similar presence of F4/80 and were significantly increased 
compared to the NF group. The H5N group also had significantly increased presence of 
F4/80 compared to the NF group, more so than any other group. Expression of F4/80 in 
these groups was predominantly localized to regions of crown like structures indicating 
activated pro-inflammatory response of macrophage infiltration. In contrast the NF and 
H9N group had decreased presence of F4/80 compared to the HF group, and it was 
primarily localized to the cell membrane, similar to what occurs in resident macrophage 
populations of healthy adipose tissue (Fig 5 B, D).  
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Figure 5-Macrophage Infiltration 
 
Legend: (A) HE staining used to identify CLS (n=5-7). There was no evident presence of 
CLS or F4/80 in the REF group. Red Arrows indicate CLS. (C) Absolute percent area of 
CLS present in visceral adipose tissue determined H9N had a significant decrease 
compared to both NF and HF groups. (B) F4/80 staining used to indicate pro-
inflammatory macrophages. Green arrows indicate F4/80 present in CLS. (D) HF, H1N, 
and H5N groups were significantly increased compared to NF group. NF and H9N group 
were decreased as compared to HF group.  
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We further assessed inflammatory activity by evaluating the cytokines Il-6, Il-1β 
Tnf-α and Il-10. Il-1β is largely derived from activated macrophages to assist in 
inflammatory response and phagocytosis. Il-1β was significantly increased in the HF, 
and H5N group, compared to the NF group, which agrees with the level of F4/80 
macrophage expression. Surprisingly, Il-1β levels were also significantly increased in 
the H9N group as compared to the NF group (Fig 6A), and this was the only cytokine of 
which H9N experienced any upregulation. The H1N offspring had the lowest expression 
of  Il-1β, however it still maintained a significant increase in expression as compared to 
the HF group.  
Il-6 was significantly overexpressed in H1N and H5N offspring compared to 
both the NF and HF offspring. H9N offspring had a reduction in expression of Il-6, 
however this was not significant compared to any group (Fig 6B). Similarities exist in 
expression levels of Tnf-α, which experienced significant upregulation in both HF and 
H1N offspring when compared to the NF offspring, although there were significant 
reductions in both H5N and H9N when compared to the HF group (Fig 6C).  
Interestingly, the H1N group had significantly increased expression of Il-10 as 
compared to both NF and HF offspring (Fig 6D), while the H5N was significantly 
increased as compared to the NF offspring. There was no significant difference in the 
H9N groups when compared to either the NF or HF groups.  
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Figure 6: Cytokine Expression in Visceral Adipose Tissue 
 
Legend: (A-D)  The adipose tissue expression of cytokines Il-6, Il-1β Tnf-α and Il-
10.were measured by real-time PCR. The expression level was analyzed using the fold 
change of the delta method. Data is reported as Mean±SEM, n=3-5. The “*” symbol 
indicates p<0.05 versus the NF group. The “#” symbol indicates p<0.05 versus the HF 
group. 
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JNK and NF-κB signaling pathways are activated by phosphorylation which is 
carried out largely by the cytokines Il-6, Il-1β and Tnf-α. H1N group experienced 
significantly upregulated ratio of phosphorylated NF-κB to NF-κB as compared to the 
HF group or NF group (Fig 7A). There was no significant difference when comparing 
the H5N group and H9N group to either the NF or HF group.  Of the three intervention 
groups, H9N had the lowest expression level, however this was not significantly 
different from the NF or HF groups.  
Ratio of pJNK/JNK was significantly increased in the H1N group, but not other 
groups, as compared to the NF group. Interestingly, the H5N group experienced a 
significant reduction in expression as compared to the HF group, while it was not 
significantly different from the NF group. pJNK/JNK in the H9N group was not 
significantly different from any group (Fig 7B).  
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Figure 7- Signaling Pathways of Inflammation 
Legend: Ratios of phosphorylated to non-phosphorylated signaling were evaluated to 
determine pro-inflammatory pathway activation. Data reported as Mean± SEM (n=3). 
 
 45 
 
A primary difficulty of elucidating offspring phenotypes in response to maternal 
diet are the confounding factors that can affect gestation such as weight gain and 
hormonal changes, gestational diabetes, and late gestation insulin resistance. By 
maintaining similar body weight of the mothers across all intervention groups at both the 
beginning of the study and after 12 weeks on HF diet we were able to eliminate 
significant influence of confounding variables (Fig 8A). Weight maintained consistent 
between the H1N, H5N and H9N groups as compared to the HF group, and this was 
continued with no significant weight gain or loss through the lactation period. This 
allows for isolation of the effects of dietary intervention. Additionally, there was no 
indication of glucose intolerance before or after pregnancy (Fig 8B-C) of any groups, 
which eliminates any potential influence of gestational diabetes and minimizes risk of 
in-utero over exposure to excess energy.  
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Figure 8- Maternal Weight and Glucose Before and After Pregnancy 
 
Legend: (A) Evaluation of maternal body weight before pregnancy and after weaning 
resulted in no significant differences. (B-C) Blood glucose levels before and after 
pregnancy did not differ significantly indicating that this did not contribute to observed 
offspring phenotypes. 
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CHAPTER V 
DISCUSSION AND CONCLUSION 
High fat diet induced obesity is associated with onset of chronic inflammation 
and development of metabolic complications and disease. Previous work from our lab 
has suggested that the effects of HFD feeding may be attenuated by transitioning the 
maternal diet prior to pregnancy in a long-term manner, and that short-term transition 
exacerbates and promotes a negative phenotype in offspring female mice (75). Our 
current study further validates this outcome in male mice.  
Increased adipocyte size is characteristic of hypertrophy and is an indication of 
obesity and increased fat mass, which is concordant with our results from the H1N and 
H5N groups. Hypertrophic adipocytes have been correlated with insulin resistance and 
aberrant insulin signaling, which may have influenced the presence of glucose 
intolerance that occurred in the H1N and H5N offspring. The H5N offspring display 
more severe glucose intolerance even though the H1N offspring had the largest visceral 
adipose tissue mass and body weight, indicating that the transition period of 5-weeks 
before pregnancy is not long enough for sufficient readjustment in the maternal body. 
Given the reduced fat mass and body weight, compared to the H1N group, the presence 
of glucose tolerance is not surprising in the H9N group.  
Further evaluation of the metabolic impacts of visceral adiposity indicated 
dysfunctional adipogenesis and fat transport in the H1N and H5N groups which was 
recovered in the H9N groups. Specifically, increased expression of Fasn is indicative of 
adipogenesis and obesity when expressed in adipose tissue (52). Expression levels that 
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occurred in all groups align with expected results based on visceral adiposity and 
adipocyte size. Expression levels of Ppar-γ and C/ebpα, which play a role in terminal 
adipocyte differentiation, were upregulated in the H1N and H5N offspring but recovered 
in the H9N offspring. Exacerbated adipocyte differentiation has been known to occur 
under conditions of obesity, as a response to manage the excessive lipid stored in 
adipose tissue (60), which may have been intensified by increased expression of genes 
regulating fatty acid uptake in the H1N and H5N offspring. This gene expression is 
concurrent with increased adipocyte fat mass deposition and adipocyte size in H1N and 
H5N offspring. Interestingly, the H9N group maintained significantly higher body 
weight and adipose tissue mass as compared to the H5N group but maintained a 
“metabolically healthy obese” phenotype with normalized adipogenesis and glucose 
tolerance, illustrating that the maternal diet transition timepoint has a distinct implication 
for metabolic programming in the offspring.  
Obesity and low-grade inflammation have been systematically linked as a trigger 
for metabolic complications and development of diseases such as Type 2 Diabetes 
Mellitus and Cardiovascular Disease. Macrophage infiltration and presence of CLS are 
potent indicators of inflammation in adipose tissues (88). While not significant, the H5N 
group had a slightly elevated presence of CLS which was supported by a significant 
increase in presence of F4/80 as compared to the NF group. Of particular note, 
expression of CD36 was also increased significantly in the H5N group as compared to 
the NF group. CD36 also plays a role in phagocytosis and macrophage response in 
adipose tissue (53) which may be associated with the slight increase in crown like 
 49 
 
structures witnessed in this group. However, the H5N group did not have activated Nf-
κB and JNK signaling, indicating a different molecular signaling pathway may be 
involved. Only H9N offspring experienced significant decrease in levels of CLS 
presence as compared to both the NF and HF groups.   
Interestingly, the H1N group had insignificant infiltration of F4/80 and CLS 
presence in adipose tissue which was contrary to expectations. However, there remained 
an increased expression of pro-inflammatory cytokines Il-6, I1-β and TNF-α and 
consequent activation of pro-inflammatory signaling pathways Nf-κB and JNK, which 
may have been perpetuated by the increased adipocyte diameter and fat mass of the H1N 
offspring.  Although the H5N offspring had higher levels of macrophage infiltration and 
CLS, there was not a concurrent expression of pro-inflammatory cytokines, indicating 
that either there was another pro-inflammatory pathway activated, or that the larger 
population of macrophages were not as potent in recruiting cytokines as were the 
enlarged adipocytes of the H1N offspring. The H9N group experienced recovery of 
macrophage infiltration, CLS, and significantly decreased expression of pro-
inflammatory cytokines which is consistent with decreased adiposity and body weight 
compared to the H1N group. Taken together, the data from macrophage infiltration, 
CLS, pro-inflammatory cytokines and pro-inflammatory signaling pathways indicates a 
distinct and significant pro-inflammatory phenotype in the H1N and H5N groups that is 
recovered in the H9N group.  
Overall, the H1N group and H5N group had significant exacerbation of both 
physical and cellular pathways of adipogenesis and inflammation. In contrast the H9N 
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group had significantly reduced inflammation and physical attributes of obesity which 
supports our hypothesis that a long-term transition can effectively reduce symptoms of 
obesity, recover dysfunctional adipogenesis, and reduce inflammation instilled by 
maternal high fat diet.  
Metabolic memory, theorized as the memory the body retains of a metabolic 
insult such as prolonged hyperglycemia in diabetes, even after normalization, has been 
widely researched as an opportunity for aggressive, early treatment for deterring 
advancement of metabolic diseases (89). In our study, we witnessed the recovery of a 
distinct metabolic phenotype which effectively reversed the damaging effects of 
maternal HFD administration. However, the mechanism of this remains unknown. If 
maternal metabolic memory was time-dependent, there would be a stepwise reduction in 
phenotype between the H1N, H5N and H9N offspring. Yet, the H5N offspring displayed 
exacerbated glucose intolerance, and increased macrophage infiltration and CLS 
presence as compared to all other groups.  Literature has noted that HFD intake 
immediately prior to conception has longstanding influences on activation of maternal 
lipogenesis genes in the placenta, leptin generation and circulation, and adiposity which 
effect offspring long term (8, 12, 68), which may provide a more concrete 
characterization of how alterations in maternal diet influence reprogramming in utero, 
especially when considering the differences in inflammatory activation between the H1N 
offspring and H5N offspring.  
Our study, for the first time, evaluated how maternal diet transition at different 
time points prior to pregnancy effects offspring outcomes of inflammation and obesity in 
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the visceral adipose tissue. Visceral adipose tissue is a driver of metabolic complications 
such as Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic 
Syndrome. Understanding how maternal dietary intake impacts offspring risk- either 
exacerbating or recovering inflammatory phenotype- has potent implications for 
reducing intergenerational risk of disease. Our work demonstrates the ability of properly 
timed maternal diet intervention to reduce risk, but also effectively illustrates that 
maternal diet if poorly timed, can exacerbate negative offspring phenotypes- in some 
instances more so than without intervention. This demonstrates the crucial need for more 
research which evaluates the mechanisms by which offspring programming occurs, and 
the critical windows that can have optimal impact and reduce serious health risk.  
Additionally, our work also serves as an evaluation on the viability of a simple 
dietary intervention without maternal weight loss on influencing offspring outcomes of 
obesity and inflammation. A widespread barrier to diet adherence and recruitment of 
women to clinical trials is that interventions are often time consuming and involve 
drastic lifestyle changes (90). Our intervention provides distinct results in recovering 
offspring health, independent of maternal weight loss. This provides viability to long 
term adherence and provides an avenue in which dietitians can become involved in 
future clinical trials through dietary coaching and education. Focusing on dietary 
intervention prior to pregnancy helps lay the framework for effective guidelines with 
feasible implementation capabilities across diverse populations.  
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APPENDIX I  
ANTIBODIES 
 
 
Nf-κB …………………………………………………Cell Signaling Technology #8242 
Phospho- Nf-κB……………………………………… Cell Signaling Technology #3033 
JNK………………………………………………….... Cell Signaling Technology #9252 
Phospho-JNK…………………………………………Cell Signaling Technology #9255 
Gapdh…………………………………………………..Cell Signaling Technology #2118 
F4/80………………………………………………….Cell Signaling Technology #70076 
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APPENDIX II  
QPCR PRIMERS 5’- 3’ 
 
 
Acacb-F GAACCGGCTTCCTGGTTG 
Acacb-R TCCTCCCCTATGCCGAAA-GA 
Cd36-F TGGAGGCATTCTCATGCC-AG 
Cd36-R TTGCTGCTGTTCTTTGCC-AC 
Fabp-F GTGGTCCGCAATGAGTTC-AC 
Fabp-R GCTTGACGACTGCCTTGA-CT 
Fas F GGAGGTGGTGATAGCCGG-TAT 
FAS F TATCAAGGAGGCCCATTT-TGC 
IL10 F GCTCTTACTGACTGGCATGAG 
IL10 R CGCAGCTCTAGGAGCATGTG 
IL1b F GCAACTGTTCCTGAACTCAACT 
IL1b R ATCTTTTGGGGTCCGTCAACT 
IL6 F TGCCTTCTTGGGACTGAT-GC 
IL6 R CTGTTGTTCAGACTCTCTCCCT 
PPARg-1F TGGTTCAAATATGCCACC-AG 
PPARg-1R CCAAGTGCTGGGATTAAA-GG 
SREBP-1c F AGCAGTCACCAGCTTCAG-TC 
SREBP-1c R GGTCATGTTGGAAACCAC-GC 
Tnf F CCCTCACACTCAGATCATCTTCT 
Tnf R GCTACGACGTGGGCTACAG 
 
 
